The Anti-Cancer Properties of Cannabidiol and Δ-9Tetrahydrocannabinol in Haematological Malignancies In Vitro Volume 5 - Issue 1

Cees Th Smit Sibinga*

• International Development of Transfusion Medicine, IQM Consulting and University of Groningen, The Netherlands

Received: October 28, 2021   Published: November 10, 2021

Corresponding author: Cees Th Smit Sibinga, Professor of International Development of Transfusion Medicine, IQM Consulting and University of Groningen, The Netherlands

DOI: 10.32474/OAJOM.2021.05.000203

 

Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Blood transfusion has been in the mind of people since ages as a substance that carries all the blessings of life, despite the serious events that happened during the époques where little or no knowledge existed on the characteristics of blood and its composition. The start of breakthroughs happened in the 19th Century, with a tremendous acceleration in the science of transfusion medicine during the 20th Century, which resulted in 23 Nobel laureates up till today [1]. With the socio-economic developments life expectancy has been improved in a growing number of populations spread over this globe [2]. With that we are now able to initiate long term observative studies to understand the slow developing effects of interventions leading to morbidities that become noticeable after years and years. Blood transfusion, be it whole blood or separated cellular components, when selected and prepared with caution and professionalism, seems time after time to generate blessings, supporting a lifesaving balance to occur in otherwise seriously life-threatening situations. That has opened numerous treatment doors for a manifold of disease entities all over the world, including the wide range of malignancies.

Introduction| Supportive Haemotherapy| Impact of Haemotherapy on the Development of Malignancies| Impact of Haemotherapy on Recurrence and Mortality in Colorectal Cancer patients| Epilogue| References|